1
|
Kizawa R, Kuno M, Washino S, Shirotake S, Izumi K, Inoue M, Kagawa M, Takeshita H, Hyodo Y, Kawakami S, Saito K, Kageyama Y, Oyama M, Miyagawa T, Miura Y. 142P The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
2
|
Nakayama T, Takeshita H, Kagawa M, Washino S, Shirotake S, Miura Y, Hyodo Y, Izumi K, Inoue M, Miyagawa T, Oyama M, Saito K, Kageyama Y, Kawakami S. 139MO Prognostic significance of the mechanism of inflammatory markers in advanced renal cell carcinoma patients treated with nivolumab plus ipilimumab. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
3
|
Yoshidome K, Morimoto T, Matsunami N, Tsunashima R, Tsukamoto F, Ryo T, Nishida Y, Shimo T, Anno K, Shimada M, Udo M, Kagawa M, Morishima H, Oda N. Abstract P6-11-17: Nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy in patients receiving neoadjuvant or adjuvant chemotherapy for breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-11-17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
A brief background discussion.
Nanoparticle albumin-bound paclitaxel (nab-PTX) has been developed under the concept of improved drug delivery. nab-PTX has been shown to significantly increase progression-free survival compared with solvent-based paclitaxel (PTX) in metastatic breast cancer. However, the long-term outcomes of nab-PTX induced peripheral neuropathy (nPIPN) have not yet been fully elucidated.
Trial design: observational cohort study (UMIN20852)
Primary objective: The long-term outcome of nPIPN
Secondary objectives
(1)The validity of the Neuropathic Pain Screening Questionnaire (Japan–Q, Ishikawa et al. Pain Research 2016 )
(2) To evaluate the effect of frozen gloves and elastic stockings for nPIPN
nPIPN was assessed by the Japan-Q (J-Q) and Common Toxicity Criteria for Adverse Events ver 4.0 (CTC). The J-Q is an assessment tool for patient-reported pain severity, which consists of seven items, each rated on a five-point scale 0-4; grade 0 (no symptoms) to grade 4 (verysevere symptoms). Pricking pain, electric shock pain, burn like pain, tingling pain with numbness, allodynia, reduced or hyper sensitivity and hand-foot syndrome. Assessment was performed every day during chemotherapy, six months and one year after completion of nab-PTX therapy. Total of 28 points for each day and 588 points for each cycle, higher point correlates with severity. Frozen gloves during administration of nab-PTX and/or elastic stockings were optionally used.
Statistical methods
Kruskal Wallis test was used and p<0.05 was considered as significant.
RESULTS:
Between May 2013, and April 2016, 105 patients were enrolled from 7 hospitals. In 73 patients (69.5%) nab-PTX was administered as primary and in 32 patients (30.5%) as adjuvant therapy. Forty three (41.0%) patients received nab-PTX as first line and 62 (59.0%) received after anthracycline contained regimen. Trastuzumab was administered as combination therapy with nab-PTX for Her2 positive patients. Both frozen gloves and stockings were used in 21 patients (20.0%) and frozen gloves only were used in 21 patients (20.0%) according to patient preference.
One hundred patients (95.2%) completed four courses, and overall relative dose intensity was 91.4%.
During chemotherapy, J-Q scores go elevated from day 1 to day 5 and gradually declined throughout the rest of the cycle. Without using frozen gloves, there was a significant increase according to courses (1st: 45.0 ± 5.7, 2nd: 76.7 ± 8.6, 3rd: 94.3 ± 11.8, 4th: 95.4 ± 11.8). Using frozen gloves, there was a significant increase from 1st course to 2nd, but no further increase was observed(1st: 37.4 ± 8.1, 2nd: 61.9 ± 12.4, 3rd: 62.9 ± 10.4, 4th: 55.3 ± 10.6). After six month and one year, the scores were significantly lower compared with the last day of the fourth cycle (4.28 ± 0.50, 2.53 ± 0.25, 2.85 ± 0.39, respectively). CTC, grade 2 or more sensory disturbance was observed in 57.9% after four cycles, but improved to 9.5% and 5.4% after six month and one year respectively.
CONCLUSIONS:
Patient-reported nPIPN was significantly getting worse without frozen gloves during chemotherapy, however be largely reversible within 1 year of PST or adjuvant treatment. The J-Q findings support that nab-PTX treatment is tolerable.
Citation Format: Yoshidome K, Morimoto T, Matsunami N, Tsunashima R, Tsukamoto F, Ryo T, Nishida Y, Shimo T, Anno K, Shimada M, Udo M, Kagawa M, Morishima H, Oda N. Nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy in patients receiving neoadjuvant or adjuvant chemotherapy for breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-11-17.
Collapse
Affiliation(s)
- K Yoshidome
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - T Morimoto
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - N Matsunami
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - R Tsunashima
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - F Tsukamoto
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - T Ryo
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - Y Nishida
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - T Shimo
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - K Anno
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - M Shimada
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - M Udo
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - M Kagawa
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - H Morishima
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| | - N Oda
- Osaka Police Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka General Medical Center, Osaka, Japan; JCHO Osaka Hospital, Osaka, Japan; Ryo Clinic, Takatsuki, Osaka, Japan; Nissay Hospital, Osaka, Japan
| |
Collapse
|
4
|
Kagawa M, Kerr D, Binns C. Ethnic Differences in the BMI-%BF Relationships between Young Japanese and Australian-Caucasian Males Living in Australia Using Dual-Energy X-ray Absorptiometry. Asia Pac J Public Health 2016; 15 Suppl:S27-32. [DOI: 10.1177/101053950301500s08] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The Body Mass Index (BMI) has been used worldwide as an indicator of fatness. However, the universal cut-off points by the World Health Organisation (WHO) classification may not be appropriate for every ethnic group when consider the relationship with their actual total body fatness (%BF). The application of population-specific classifications to assess BMI may be more relevant to public health. Ethnic differences in the BMI-%BF relationship between 45 Japanese and 42 Australian-Caucasian males were assessed using whole body dual-energy X-ray absorptiometry (DXA) scan and anthropometry using a standard protocol. Japanese males had significantly ( p<0.05) greater %BF at given BMI values than Australian males. When this is taken into account the newly proposed Asia-Pacific BMI classification of BMI >23 as overweight and >25 as obese may better assess the level of obesity that is associated increased health risks for this population. To clarify the current findings, further studies that compare the relationships across other Japanese populations are recommended.
Collapse
Affiliation(s)
- M Kagawa
- School of Public Health, Curtin University of Technology, Perth, Australia
| | - D Kerr
- School of Public Health, Curtin University of Technology, Perth, Australia
| | - C Binns
- School of Public Health, Curtin University of Technology, Perth, Australia
| |
Collapse
|
5
|
Nakayama T, Yasojima H, Morimoto T, Yoshidome K, Mizutani M, Takashima T, Matsunami N, Enami A, Kagawa M, Nomura T, Shiba E, Nishi T, Kamigaki S, Kozuma Y, Yoshinami T, Masuda N. Abstract P1-10-26: Frozen glove could be a new hope for prevention of chemotherapy induced peripheral neuropathy. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p1-10-26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction
Chemotherapy induced peripheral neuropathy (CIPN) is a major problem for patients who receive chemotherapy, and it sometimes deteriorate patients' QOL. Many CIPN prevention trials have been conducted, but no one succeeded to date.
Objectives
To investigate if frozen glove (FG) prevents peripheral neuropathy induced by nanoparticle albumin-bound paclitaxel (nab-PTX).
Methods
We conducted CIPN prevention study using FG, as part of multi-institutional phase II study which analyze efficacy and safety of nab-PTX (260mg/m2 q3w) followed by FEC (500/100/500 mg/m2, q3w) in pre-operative setting (KBCSG-TR 1213 trial). Each patient wore an FGs for a total of 60 minutes (15mins before and after nab-PTX treatment) on both hands. CIPN were assessed during treatment period with nab-PTX by the Patient Neurotoxicity Questionnaire (PNQ) and the FACT/GOG (Gynecologic Oncology Group) Neurotoxicity (Ntx) subscale. Patients were asked to access PNQ and FACT/GOG Ntx on a daily basis and recorded in the CIPN diary.
Results
Sixty two patients were registered for KBCSG-TR 1213 trial. And forty two pts (68%) who turned in the diary were analyzed. Median age and median body mass index (BMI) was 48 years old and 21.6 kg/m2, respectively. We analyzed following 6 categories, 1) symptoms of hands and arms, 2) symptoms of foots, 3) symptoms of general, 4) symptoms of ears 5) muscle weakness of hands and arms and 6) muscle weakness of foots. Median time to each event was 1) 25.5 days, 2) 5days, 3) 3days, 4) not available, 5) 46.5days, 6)4 days. By using FG, time to event of hands and arms was much longer compared with that of foots.
Conclusions
CIPN could be prevented or lessened by FG. Randomized phase II CIPN prevention study has been just launched.
Citation Format: Nakayama T, Yasojima H, Morimoto T, Yoshidome K, Mizutani M, Takashima T, Matsunami N, Enami A, Kagawa M, Nomura T, Shiba E, Nishi T, Kamigaki S, Kozuma Y, Yoshinami T, Masuda N. Frozen glove could be a new hope for prevention of chemotherapy induced peripheral neuropathy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-10-26.
Collapse
Affiliation(s)
- T Nakayama
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - H Yasojima
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Morimoto
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - K Yoshidome
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - M Mizutani
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Takashima
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - N Matsunami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - A Enami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - M Kagawa
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Nomura
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - E Shiba
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Nishi
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - S Kamigaki
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - Y Kozuma
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Yoshinami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - N Masuda
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| |
Collapse
|
6
|
Ward LC, Isenring E, Dyer JM, Kagawa M, Essex T. Resistivity coefficients for body composition analysis using bioimpedance spectroscopy: effects of body dominance and mixture theory algorithm. Physiol Meas 2015; 36:1529-49. [PMID: 26034992 DOI: 10.1088/0967-3334/36/7/1529] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Body composition is commonly predicted from bioelectrical impedance spectroscopy using mixture theory algorithms. Mixture theory algorithms require the input of values for the resistivities of intra-and extracellular water of body tissues. Various derivations of these algorithms have been published, individually requiring resistivity values specific for each algorithm. This study determined apparent resistivity values in 85 healthy males and 66 healthy females for each of the four published mixture theory algorithms. The resistivity coefficients determined here are compared to published values and the inter-individual (biological) variation discussed with particular reference to consequential error in prediction of body fluid volumes. In addition, the relationships between the four algorithmic approaches are derived and methods for the inter-conversion of coefficients between algorithms presented.
Collapse
Affiliation(s)
- L C Ward
- School Chemistry and Molecular Biosciences, The University of Queensland, Australia
| | | | | | | | | |
Collapse
|
7
|
Shultz SP, Kagawa M, Fink PW, Hills AP. Knee alignment can help predict sedentary behaviour in children: a pilot study. J Sports Med Phys Fitness 2014; 54:631-635. [PMID: 24710394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
AIM The purpose of this pilot study was to introduce knee alignment as a potential predictor of sedentary activity levels in boys and girls. METHODS Dual energy x-ray absorptiometry (DXA) and anthropometric assessment were conducted on 47 children (21 boys and 26 girls; 5-14 y) and their gender-matched parent. Body Mass Index (BMI) and abdominal-to-height ratio were calculated. Lower extremity alignment was determined by anatomic tibiofemoral angle (TFA) measurements from DXA images. Time spent in moderate-to-vigorous physical activity and sedentary activities were obtained from a parent-reported questionnaire. Stepwise multiple regression analyses identified anthropometric, musculoskeletal, and activity factors of parents and children for predicting total time spent in sedentary behaviour. RESULTS Weight, total sedentary time of parents and TFA are moderate predictors of sedentary behaviour in children (R2=0.469). When stratifying for gender, TFA and total sedentary time of the parent, as well as waist circumference, are the most useful predictors of sedentary behaviour in boys (R2=0.648). However, weight is the only predictor of sedentary behaviour in girls (R2=0.479). CONCLUSION Negative associations between TFA and sedentary behaviour indicate that even slight variations in musculoskeletal alignment may influence a child's motivation to be physically active. Although growth and development is complicated by many potentialities, this pilot study suggests that orthopaedic factors should also be considered when evaluating physical activity in children.
Collapse
Affiliation(s)
- S P Shultz
- School of Human Movement Science, Institute of Health and Biomedical Innovation Queensland University of Technology, Brisbane, Australia -
| | | | | | | |
Collapse
|
8
|
Kasamatsu C, Kimura S, Kagawa M, Hatae K. Identification of High Molecular Weight Proteins in Squid Muscle by Western Blotting Analysis and Postmortem Rheological Changes. Biosci Biotechnol Biochem 2014; 68:1119-24. [PMID: 15170118 DOI: 10.1271/bbb.68.1119] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The high molecular weight protein connectin (also called titin) in Japanese common squid (Todarodes pacificus) mantle muscle was identified by western blotting analysis with 3B9, the mouse anti-chicken skeletal muscle connectin monoclonal antibody. Similarly to vertebrate samples, there exists connectin in invertebrate squid mantle muscle, and the amino acid sequences are assumed to resemble those present in the A band of vertebrate connectin, judging by the specificity of 3B9. Moreover, the connectin in squid muscle migrated in this study as a closely spaced doublet of alpha and beta (titins 1 and 2). Between 5 and 7 h post-mortem, the SDS PAGE patterns of the squid sample indicated a change of the doublet bands into a single beta-connectin band. Simultaneously, the rheological properties of the squid muscle changed substantially. This degradation of alpha-connectin into beta-connectin in the muscle can explain the critical change that occurs during the post-mortem tenderization of squid muscle.
Collapse
Affiliation(s)
- Chinatsu Kasamatsu
- School of Human Life and Environmental Science, Ochanomizu University, Tokyo, Japan.
| | | | | | | |
Collapse
|
9
|
Nishida S, Surblys D, Yamaguchi Y, Kuroda K, Kagawa M, Nakajima T, Fujimura H. Molecular dynamics analysis of multiphase interfaces based on in situ extraction of the pressure distribution of a liquid droplet on a solid surface. J Chem Phys 2014; 140:074707. [DOI: 10.1063/1.4865254] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Surblys D, Yamaguchi Y, Kuroda K, Kagawa M, Nakajima T, Fujimura H. Molecular dynamics analysis on wetting and interfacial properties of water-alcohol mixture droplets on a solid surface. J Chem Phys 2014; 140:034505. [DOI: 10.1063/1.4861039] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Kitaguchi S, Kagawa M, Yamaguchi K, Watanabe M, Ogawa T, Furonaka O, Sugahara F, Egawa H. The Combination Chemotherapy of Carboplatin and Weekly Paclitaxel Plus Bevacizumab in Patients with Advanced NSCLC. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt459.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Imai T, Maruyama S, Takahashi T, Uchida H, Koda M, Yamamoto H, Kagawa M. Discrepancies in body perceptions between preschoolers and their mothers. Obes Res Clin Pract 2013. [DOI: 10.1016/j.orcp.2013.08.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Hastuti J, Kagawa M, Byrne N, Hills A. Obesity screening for Indonesian adults using BMI and percentage body fat: Redefined cut-off points. Obes Res Clin Pract 2013. [DOI: 10.1016/j.orcp.2013.08.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Iihara N, Nishio T, Okura M, Anzai H, Kagawa M, Houchi H, Kirino Y. Comparing patient dissatisfaction and rational judgment in intentional medication non-adherence versus unintentional non-adherence. J Clin Pharm Ther 2013; 39:45-52. [PMID: 24106917 DOI: 10.1111/jcpt.12100] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2013] [Accepted: 09/02/2013] [Indexed: 11/30/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Patients' poor adherence to medications is reported to be related to the individual patients' beliefs and cognitions and their trust of the medical staff. However, the causes of the two forms of non-adherence, intentional and unintentional behaviours, have yet to be clarified. This study compared psychological latent factors associated with intentional and unintentional non-adherence to chronic medication regimens, focusing on the potential effects of (i) patients' dissatisfaction with treatment and their relationships with the medical staff and (ii) patients' subliminal rational thinking processes, which weighed the positive values such as their expectations of benefits from treatment against negative values such as their dissatisfaction. METHODS Two cross-sectional surveys were undertaken of patients given medications for chronic diseases, using a questionnaire developed and validated in this study. One survey was undertaken in three hospitals and the other survey, online throughout Japan. We scored the individual latent factors using the questionnaire and calculated the differential score between two negatively correlated latent factors to quantify patients' subliminal rational thinking process. We compared the adjusted odds ratio (OR) of latent factors between intentional and unintentional non-adherence to medication in both surveys. RESULTS AND DISCUSSION Of the eligible subjects, 149 hospitalized patients and 524 survey participants completed the questionnaire. Intentional non-adherence was associated with patient dissatisfaction with treatment including interpersonal relationships with medical staff in both hospitalized patients and online survey participants (95% confidence interval of adjusted OR for Dissatisfaction, 1·20-16·26 in the hospital-based survey and 1·33-3·45 in the online survey). In both surveys, intentional non-adherence was significantly associated with the differential score between two negatively correlated latent factors, Willingness and Dissatisfaction (P = 0·02 in the hospital-based survey and P < 0·001 in the online survey). However, these associations were not evident in unintentionally non-adherent patients. WHAT IS NEW AND CONCLUSIONS Patients' dissatisfaction and their resulting rational judgments are unique, consistent determinants of intentional non-adherence to medications, but not of unintentional non-adherence.
Collapse
Affiliation(s)
- N Iihara
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Japan
| | | | | | | | | | | | | |
Collapse
|
15
|
Njiru J, Biryabarema C, Kagawa M. FETAL OUTCOMES AMONG GRAND MULTIPAROUS AND MULTIPAROUS WOMEN IN MULAGO HOSPITAL, UGANDA. East Afr Med J 2013; 90:84-88. [PMID: 26866106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE To compare fetal outcomes among grand multiparous (para 5-9) and multiparous (para 2-4) delivering in Mulago hospital, Uganda. DESIGN Prospective cohort study. SETTING Mulago hospital, Uganda. SUBJECTS One hundred and fifty six grand multiparous and multiparous women were recruited on admission in labourward and followedup through labour and immediate postpartum period. Fetal outcomes among the two groups were collected and analyzed. RESULTS The admissions to SCU were similar in the two groups i.e. 11(7%) GMP vs. 11(7%) MP, the number of fresh still births was higher among the grandmultiparas 13(8.3%) GMP vs. 7(4.5%) MP though this was not statistically significant. The fetal weight did not significantly differ in the two groups. CONCLUSION There was no difference in fetal outcomes among GMPs when compared to MPs.
Collapse
|
16
|
Tsiros MD, Buckley JD, Howe PRC, Olds T, Walkley J, Taylor L, Mallows R, Hills AP, Kagawa M, Coates AM. Day-to-day physical functioning and disability in obese 10- to 13-year-olds. Pediatr Obes 2013; 8:31-41. [PMID: 22962042 DOI: 10.1111/j.2047-6310.2012.00083.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2012] [Revised: 05/10/2012] [Accepted: 06/15/2012] [Indexed: 12/20/2022]
Abstract
UNLABELLED What is already known about this subject? Compared with their healthy-weight peers, children with obesity have; impaired physical health-related quality of life reduced physical activity levels reduced capacity to perform certain weight-bearing tasks in field-based fitness tests What this study adds? First investigation of obesity-related disability in children using the International Classification for Functioning, Disability and Health framework for Children and Youth. Obesity in children appears to be associated with disability impacting basic locomotor skills and physical health-related quality of life. Children's participation in key life areas related to physical functioning appears to be minimally impacted by obesity. OBJECTIVE The aim of this study was to investigate whether obesity is related to impaired day-to-day physical functioning and disability in children. METHODS An observational case-control study was conducted in three Australian states. Obese (n = 107) and healthy-weight (n = 132) 10- to 13-year-olds (132 male, 107 female) were recruited via media advertisements. Assessment of body composition (dual energy X-ray absorptiometry), locomotor capacity (six-minute walk test [6MWT], timed up and down stairs test [TUDS] and timed up and go [TUG]) and child-reported physical health-related quality of life (HRQoL) were undertaken. Participants wore an accelerometer for 8 days and completed two use-of-time telephone interviews to assess participation in key life areas. RESULTS Compared with their healthy-weight counterparts, obese children had lower physical HRQoL scores (P < 0.01) and reduced locomotor capacity (TUDS z-score, TUG and 6MWT; P < 0.01). Higher percent body fat was significantly related to lower physical HRQoL scores (r = -0.48, P < 0.01), slower performance times for the TUDS and TUG (r = 0.59 and 0.26 respectively, P < 0.01), shorter 6MWT distances (r = -0.51, P < 0.01) and reduced time spent in community participation activities (r = -0.23, P < 0.01). CONCLUSIONS As anticipated, obesity appears to undermine physical functioning in children, including the capacity to perform basic locomotor skills yet, unexpectedly, participation in key life areas related to physical functioning appeared largely unaffected.
Collapse
Affiliation(s)
- M D Tsiros
- Nutritional Physiology Research Centre, School of Health Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Tsiros M, Coates A, Howe P, Grimshaw P, Walkley J, Shield A, Mallows R, Hills A, Kagawa M, Shultz S, Buckley J. Differences in knee extensor strength in healthy-weight and obese children. Obes Res Clin Pract 2012. [DOI: 10.1016/j.orcp.2012.08.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Kagawa M, Yoshida Y, Kubota M, Kurita A, Matsui T. Non-contact heart rate monitoring method for elderly people In bed with random body motions using 24 GHz dual radars located beneath the mattress In clinical settings. J Med Eng Technol 2012; 36:344-50. [DOI: 10.3109/03091902.2012.697533] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
19
|
Gotoh S, Sun G, Kagawa M, Matsui T. A novel stress monitoring method through stress-induced respiratory alterations: non-contact measurement of respiratory V(T)/T(I) alterations induced by stressful sound using a 10 GHz microwave radar. J Med Eng Technol 2011; 35:416-9. [PMID: 22059799 DOI: 10.3109/03091902.2011.626836] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
We have developed a non-contact stress monitoring system which measures respiratory V(T)/T(I) (tidal volume/inspiration time) alterations using a 10 GHz microwave radar. The measurable distance of the system is 50 cm, which is 10 times longer than our previously developed stress monitoring system which measures heart rate variability using a 24-GHz microwave-radar. The study was conducted with eight subjects (23 ± 1 years old) to evaluate the efficacy of the system. An audio stimulus at 95 dB sound pressure level was presented to the subjects following a silent period of 120 seconds. During the silent period, V(T)/T(I) averaged 826 ± 384 ml s(-1), while it increased significantly (p < 0.05) with an average of 1227 ± 704?ml s(-1) during audio stimulus low frequency component (LF)/high frequency component (HF), which reflects sympatho-vagal valance, showed a peak during audio stimuli. This paper aims to study the efficacy of the non-contact stress monitoring system for its future applications in many fields including health and safety.
Collapse
Affiliation(s)
- S Gotoh
- Department of Management Systems Engineering, Tokyo Metropolitan University , 6-6 Asahigaoka, Hino, Tokyo 191-0065, Japan
| | | | | | | |
Collapse
|
20
|
Tsiros M, Buckley J, Howe P, Olds T, Walkley J, Taylor L, Mallows R, Hills A, Kagawa M, Coates A. Obesity the new disability? Investigating the impact of fatness on day-to-day physical functioning in 10–13 year olds. Obes Res Clin Pract 2011. [DOI: 10.1016/j.orcp.2011.08.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Liu A, Byrne NM, Ma G, Nasreddine L, Trinidad TP, Kijboonchoo K, Ismail MN, Kagawa M, Poh BK, Hills AP. Validation of bioelectrical impedance analysis for total body water assessment against the deuterium dilution technique in Asian children. Eur J Clin Nutr 2011; 65:1321-7. [DOI: 10.1038/ejcn.2011.122] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
22
|
Shultz S, Hills A, Byrne N, Kagawa M. Factors affecting energy cost of walking in obese youth. Obes Res Clin Pract 2010. [DOI: 10.1016/j.orcp.2010.09.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
23
|
Karaki M, Kagawa M, Ishii G, Tamiya T, Mori N. Effectiveness of Endoscopic Endonasal Transethmoidal Orbitotomy for Upper Orbital Subperiosteal Lesions. Skull Base 2009. [DOI: 10.1055/s-2009-1224442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
24
|
Kagawa M, Kuroiwa C, Uenishi K, Mori M, Dhaliwal S, Hills AP, Binns CW. A comparison of body perceptions in relation to measured body composition in young Japanese males and females. Body Image 2007; 4:372-80. [PMID: 18089283 DOI: 10.1016/j.bodyim.2007.06.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/30/2006] [Revised: 06/11/2007] [Accepted: 06/13/2007] [Indexed: 11/27/2022]
Abstract
The body composition of 139 Japanese females and 84 Japanese males (aged 18-30 years) was measured using anthropometry to assess gender differences in body perceptions in relation to their measured values. Participants were asked to rate perceptions of their own "heaviness" and "fatness" and these were compared to their BMI and percent body fat (%BF). Japanese females showed a significantly greater desire to lose body weight (-4.20+/-0.6 kg) compared to males (0.27+/-1.4 kg). Females also showed poor understanding of their "heaviness" and "fatness" in relation to actual body composition compared to males. The results confirmed distinct gender differences in body perception in relation to actual body composition and attitudes to weight management. Further promotion of "healthy" body image is recommended for the Japanese population.
Collapse
Affiliation(s)
- M Kagawa
- School of Public Health, Curtin University of Technology, Australia.
| | | | | | | | | | | | | |
Collapse
|
25
|
Kerr DA, Ross WD, Norton K, Hume P, Kagawa M, Ackland TR. Olympic lightweight and open-class rowers possess distinctive physical and proportionality characteristics. J Sports Sci 2007; 25:43-53. [PMID: 17127580 DOI: 10.1080/02640410600812179] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Rowers competing at the 2000 Olympic Games were measured for 38 anthropometric dimensions. The aim was to identify common physical characteristics that could provide a competitive advantage. The participants included 140 male open-class rowers, 69 female open-class rowers, 50 male lightweight rowers, and 14 female lightweight rowers. Body mass, stature, and sitting height were different (P < 0.01) between the open-class and lightweight rowers, as well as a comparison group of healthy young adults ("non-rowers", 42 males, 71 females), for both sexes. After scaling for stature, the open-class rowers remained proportionally heavier than the non-rowers, with greater proportional chest, waist, and thigh dimensions (P < 0.01). Rowers across all categories possessed a proportionally smaller hip girth than the non-rowers (P < 0.01), which suggested the equipment places some constraints on this dimension. Top-ranked male open-class rowers were significantly taller and heavier and had a greater sitting height (P < 0.01) than their lower-ranked counterparts. They were also more muscular in the upper body, as indicated by a larger relaxed arm girth and forearm girth (P < 0.01). For the male lightweight rowers, only proportional thigh length was greater in the best competitors (P < 0.01). In the female open-class rowers, skinfold thicknesses were lower in the more highly placed competitors (P < 0.01). In conclusion, the rowers in this sample demonstrated distinctive physical characteristics that distinguish them from non-rowers and other sports performers.
Collapse
Affiliation(s)
- D A Kerr
- Curtin University of Technology, Perth, WA, Australia.
| | | | | | | | | | | |
Collapse
|
26
|
Kagawa M, Kuroiwa C, Uenishi K, Mori M, Ishida H, Binns C. 85 Estimation of body fat in Japanese females using anthropometry, multi-frequency bioelectrical impedance analysis (MFBIA), and dual energy X-ray absorptiometry. J Sci Med Sport 2005. [DOI: 10.1016/s1440-2440(17)30580-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
27
|
Kagawa M, Machida Y, Nishi H, Haginaka J. Direct Enantiomeric Purity Determination of Acetyl-L-carnitine by LC with a Ligand-Exchange Chiral Stationary Phase. Chromatographia 2005. [DOI: 10.1365/s10337-005-0610-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
28
|
Maeshima S, Kagawa M, Kishida Y, Kobayashi K, Makabe T, Morita Y, Kunishio K, Matsumoto A, Tsubahara A. Unilateral spatial neglect related to a depressed skin flap following decompressive craniectomy. Eur Neurol 2004; 53:164-8. [PMID: 15942242 DOI: 10.1159/000086129] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/28/2004] [Indexed: 11/19/2022]
Affiliation(s)
- S Maeshima
- Department of Physical Medicine and Rehabilitation, Kawasaki Hospital, Okayama, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Onodera K, Kawaguch M, Shibata M, Kagawa M, Kojima J, Shimizu K, Yoneko M, Wachi M. Toxicological study of a glucose-added acetic acid maintenance infusion solution (VEEN 3G Inj.) local irritation test. Drugs Exp Clin Res 2002; 28:17-25. [PMID: 12073764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
The local irritating effect of Veen 3G Inj. (glucose-added acetic acid maintenance infusion solution) was examined in male rabbits. We studied the local irritating effect of the infusion solution compared with that of Ringer's solution, 5% sulfobromophthalein sodium injection, distilled water for injection or glucose-added Ringer's solution. In the vascular irritation test, macroscopical and histopathological changes induced by the infusion solution were not observed in the vessels. Moreover, in the hemolytic test, hemolysis of rabbit erythrocyte was not observed in the mixture with the infusion solution. In the present study, no change suggesting irritation by the infusion solution was observed in the in vivo vascular irritation test using the auricular vein of rabbits or in the in vitro hemolytic test using rabbit erythrocyte. In conclusion, in clinical use the infusion solution produces extremely slight adverse effects, such as vessel pain and phlebitis on the injection site.
Collapse
Affiliation(s)
- K Onodera
- Department of Dental Pharmacology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Kamei J, Onodera K, Kawaguchi M, Shibata M, Kagawa M, Wachi M, Kojima J. Toxicological study of a new maintenance fluid, Veen 3G, in rats. Methods Find Exp Clin Pharmacol 2002; 24:493-6. [PMID: 12500428 DOI: 10.1358/mf.2002.24.8.705069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
A study of the different volume and infusion rates of a new maintenance fluid, Veen 3G, on the general conditions of rats was investigated during the 14 days after infusion. In Experiment I, 100 ml/kg and 200 ml/kg of Veen 3G were infused at a rate of 300 ml/kg/h in male and female rats. Results were compared with those for Gurunon Ringer solution (GRS) in male and female rats. We observed only transient polyuria in animals administered by each dose of Veen 3G and GRS for 0-15 min after infusion. Necropsy was not observed in any of the animals tested 14 days after infusion. In Experiment II, 200 ml/kg of Veen 3G was infused at rates of 200, 400, 800 and 1600 ml/kg/h in male rats. At 800 and 1600 ml/kg/h, irregular respiration and decrease in movement were observed concomitantly with polyuria. Three out of 4 rats died immediately after the infusion of Veen 3G at a rate of 1600 ml/kg/h, and one rat was still alive 14 days after the infusion. In this experiment, 200 ml/kg Veen 3G was safe when we infused at a rate of less than 400 ml/kg/h in male rats. Since this rate is about 27-80 times higher than that used clinically in maintenance treatment, Veen 3G is suggested to be safe, with the exception of polyuria, in clinical situations at the standard infusion rate (5-15 ml/kg/h).
Collapse
Affiliation(s)
- J Kamei
- Department of Pathophysiology and Therapeutics Faculty of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
31
|
Kagawa M. [A guide line for antibiotic therapy of infectious diseases of the central nervous system]. Nihon Geka Gakkai Zasshi 2001; 102:837-41. [PMID: 11828707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
The purpose of this paper is to provide assistance to clinicians in the treatment of infectious diseases of the central nervous system. Antibiotic therapy should be initiated as soon as the diagnosis is made and should not be delayed until the next scheduled dose or until investigations have been performed. The infecting organism is usually unknown when treatment is initiated and often remains so, and therefore empirical therapy should always cover the most common suspected organisms. The choice of antibiotics, dosage, and route of administration depends upon the severity of illness. Likely pathogens and the known sensitivities of pathogens of the central nervous system are discussed.
Collapse
Affiliation(s)
- M Kagawa
- Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan
| |
Collapse
|
32
|
Kawaguchi M, Nagaoka Y, Kagawa M, Kasai Y, Wachi M. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 14). Comparison of the effects of 2- and 4-weeks intravenous administration of etoposide. J Toxicol Sci 2001; 25 Spec No:145-53. [PMID: 11349438 DOI: 10.2131/jts.25.specialissue_145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
In order to examine whether effects on male reproductive organs following 2-weeks administration of Etoposide (ET) are detectable, ET was administered intravenously once a week to rats for 2 and 4 weeks at 5 and 10 mg/kg/week. No deaths and no drug-related changes in body weight or in gross pathology were observed. However, decreased testis and/or thymus weights were noted. And histopathological examination revealed decrease and/or loss of spermatogonia and spermatocytes in the testes. It was evident that the target cells of the test article in the male reproductive organs are spermatogonia. Atrophy of the medulla and increase of immature lymphocytes in the cortex of the thymus and increase of fatty cells and increase of immature hematopoietic cells in the bone marrow were also apparent. The histological changes in the testis, thymus and bone marrow suggest that ET inhibits cellular mitosis which reflects its mechanism of action as an anticancer agent. It is concluded that effects of ET on male reproductive organs can be detected by histopathological examination of the testes after 2-weeks repeated administration.
Collapse
Affiliation(s)
- M Kawaguchi
- Toxicology Group, Omiya Research Laboratory, Nikken Chemicals Co., Ltd., 1-346 Kitabukuro-cho, Omiya-shi, Saitama 330-0835, Japan
| | | | | | | | | |
Collapse
|
33
|
Mizobata T, Kagawa M, Murakoshi N, Kusaka E, Kameo K, Kawata Y, Nagai J. Overproduction of Thermus sp. YS 8-13 manganese catalase in Escherichia coli production of soluble apoenzyme and in vitro formation of active holoenzyme. Eur J Biochem 2000; 267:4264-71. [PMID: 10866831 DOI: 10.1046/j.1432-1033.2000.01474.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Overproduction of Thermus sp. YS 8-13 manganese catalase in Escherichia coli BL21(DE3) was accomplished by introducing a derivative of pET-23a(+) containing a copy of the coding gene into the multicloning site. E. coli BL21(DE3)/pETMNCAT produced abundant quantities of manganese catalase as insoluble inclusion bodies. Regeneration of active catalase was achieved by denaturation in guanidine hydrochloride and subsequent dialysis in the presence of manganese ion. When the E. coli chaperone genes GroEL, GroES, DnaK, DnaJ and GrpE were coexpressed with manganese catalase, a significant fraction of the overproduced protein was partitioned into the soluble fraction. However, almost all of the soluble enzyme was isolated in a manganese-deficient apo form which could subsequently be converted into active holoenzyme by incubation with manganese ion at high temperatures. Further experiments on this apo catalase suggested that the structure of this protein was virtually identical to the active holoenzyme.
Collapse
Affiliation(s)
- T Mizobata
- Department of Biotechnology, Faculty of Engineering, Tottori University, Japan.
| | | | | | | | | | | | | |
Collapse
|
34
|
Shibata M, Wachi M, Kagawa M, Kojima J, Onodera K. Acute and subacute toxicities of theophylline are directly reflected by its plasma concentration in dogs. Methods Find Exp Clin Pharmacol 2000; 22:173-8. [PMID: 10893701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
The purpose of this study was to evaluate the relationship between acute and subacute toxicity and blood levels of theophylline in dogs. Theophylline was administered intravenously into dogs once (at doses of 50, 100 and 150 mg/kg) or for 4 weeks (at doses of 20, 35 and 70 mg/kg/day). In the single dose toxicity study, by increasing the dose of theophylline, plasma concentration increased and the severity of toxic symptoms were intensified. After a single dosing of theophylline, accentuated heart rate and vomiting were observed at a concentration of more than 67 micrograms/ml, and excitement, spasm and hyperpnea were observed at more than 130 micrograms/ml. Animals died after tonic convulsion at 180 micrograms/ml. In the repeated dose toxicity study, the plasma concentration of theophylline increased dependent on dosage, and was not affected by repeated dosing. Even under these conditions, the toxic symptoms were quite similar to those of the single dose, except for an additional decrease in movement, body weight reduction and myocardial lesion. These present results suggest that the severity of theophylline toxicity is dependent on its plasma concentrations rather than accumulated dosages. The blood concentration of theophylline-treated patients should be maintained within the therapeutic range in order to diminish risk.
Collapse
Affiliation(s)
- M Shibata
- Omiya Research Laboratory, Nikken Chemicals Co., Ltd., Saitama, Japan.
| | | | | | | | | |
Collapse
|
35
|
Abstract
Forms of vitamin B12 (B12) compounds in young and aged corbiculas were examined by bioautography using B12-requiring microorganisms combined with cellulose acetate membrane electrophoresis or high-performane liquid chromatography (HPLC). Both corbiculas (per 100 g) contained ca. 30 microg of cobalamin, a complete type of B12. Five known B12 compounds, adenosylB12 (AdoB12), methylB12, hydroxoB12, sulfitoB12 and cyanoB12, were identified by bioautography. Young corbicula contained more B12 compounds, assumed as methylB12, AdoB12 and sulfitoB12, as compared to aged corbicula. All of the B12 compounds detected around the location corresponding to those of methylB12, AdoB12 and sulfitoB12 in the bioautography were converted into compounds that behaved like hydroxoB12 after photolysis. Young corbicula was found to contain an unidentified B12 compound using bioautography combined with HPLC. A large portion of the B12 compound that moved like hydroxoB12 during cellulose acetate membrane electrophoresis using 0.5 N acetic acid might be identical with the unidentified B12 compound detected in the HPLC-bioautography.
Collapse
Affiliation(s)
- K Mizoguchi
- Faculty of Education, Hiroshima University, Kagamiyama, Japan
| | | | | | | |
Collapse
|
36
|
Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999; 73:8053-63. [PMID: 10482554 PMCID: PMC112821 DOI: 10.1128/jvi.73.10.8053-8063.1999] [Citation(s) in RCA: 204] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Human herpesvirus 6 (HHV-6), which belongs to the betaherpesvirus subfamily and infects mainly T cells in vitro, causes acute and latent infections. Two variants of HHV-6 have been distinguished on the basis of differences in several properties. We have determined the complete DNA sequence of HHV-6 variant B (HHV-6B) strain HST, the causative agent of exanthem subitum, and compared the sequence with that of variant A strain U1102. A total of 115 potential open reading frames (ORFs) were identified within the 161,573-bp contiguous sequence of the entire HHV-6 genome, including some genes with remarkable differences in amino acid identity. All genes with <70% identity between the two variants were found to contain deleted regions when ORFs that could not be expressed were excluded from the comparison. Except in the case of U47, these differences were found in immediate-early/regulatory genes, DR2, DR7, U86/90, U89/90, and U95, which may represent characteristic differences of variants A and B. Also, we have successfully typed 14 different strains belonging to variant A or B by PCR using variant-specific primers; the results suggest that the remarkable differences observed were conserved evolutionarily as variant-specific divergence.
Collapse
Affiliation(s)
- Y Isegawa
- Department of Microbiology, Osaka University Medical School C1, 2-2 Yamada-Oka Suita, Osaka 565-0871, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Kagawa M, Machida Y, Nishi H. Enantiomeric purity determination of acetyl-L-carnitine by reversed-phase high-performance liquid chromatography using chiral derivatization. J Chromatogr A 1999; 857:127-35. [PMID: 10536831 DOI: 10.1016/s0021-9673(99)00780-3] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
An indirect HPLC enantioseparation method for the determination of acetyl-D-carnitine (D-AC) in acetyl-L-carnitine (L-AC) was developed. L-AC was derivatized with a chiral amino compound which has a chromophore for UV detection. Six chiral amino compounds were examined as chiral derivatization reagents. Among them, enantiomers of acetylcarnitine derivatized with L-alanine-beta-naphthylamide (L-Ala-beta-NA) were successfully separated on an ODS column within 10 min with Rs = 1.94 and alpha = 1.10. Quantitation was achieved through UV detection at 254 nm. The derivatization reaction of L-AC with L-Ala-beta-NA was completed in less than 10 min at room temperature (ca. 20 degrees C). Validation data such as linearity, detection limit, and precision are also presented. The detection limit of D-AC in L-AC in this method was below 0.05% (visual evaluation). This method was found to be applicable as a practical quality control method for the enantiomeric purity determination of L-AC.
Collapse
Affiliation(s)
- M Kagawa
- Analytical Research Laboratory, Tanabe Seiyaku Co. Ltd., Osaka, Japan.
| | | | | |
Collapse
|
38
|
Yoshitake K, Yokota K, Kasugai Y, Kagawa M, Sukamoto T, Nakamura T. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet. Bone 1999; 25:311-9. [PMID: 10495135 DOI: 10.1016/s8756-3282(99)00172-6] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Tibolone is a synthetic steroid with tissue-specific estrogenic, progestogenic, and androgenic properties. The therapeutic effects of tibolone on bone mass and strength, bone metabolic markers, and indices of histomorphometry were investigated in ovariectomized (ovx) rats on a low (0.1%)-calcium diet in comparison with 17alpha-ethynylestradiol (EE) or 1alpha-hydroxyvitamin D3 [1alpha(OH)D3]. Tibolone (0.1-3 mg/kg/day), EE (0.1 mg/kg/day), or 1alpha(OH)D3 (0.5 microg/kg/day) was administered orally once a day for 16 weeks, starting 12 weeks after ovariectomy, when the bone mineral density (BMD) of lumbar vertebrae (L4-5) and femur (global, proximal, and distal regions) had already been decreased by the combination of ovariectomy and low dietary calcium. The BMD of the lumbar vertebrae and the femur were higher in the groups treated with tibolone, EE, or 1alpha(OH)D3 than in the ovx control group. The BMD of the mid-diaphysial regions of femur and tibia, which consist mainly of cortical bone, were decreased 28 weeks after ovariectomy in the ovx control group. The BMD of the mid-diaphysial femur was higher in the groups treated with 1alpha-(OH)D3, and the BMD of mid-diaphysial tibia was higher in the groups treated with tibolone or 1alpha(OH)D3 than in the ovx control group. Like BMD, the compressive strength of the vertebral body of L2, corrected for the volume of each individual vertebra tested, was higher in the groups treated with tibolone, EE, or 1alpha(OH)D3 than in the ovx control group. Trabecular bone volume and trabecular number were reduced 12 and 28 weeks after ovariectomy but there was no change in trabecular thickness. These reduced indices were increased in the groups treated with tibolone, EE, or 1alpha(OH)D3 when compared with the ovx control group. Tibolone or EE decreased serum levels of osteocalcin and bone alkaline phosphatase and urinary levels of deoxypyridinoline and pyridinoline compared with the ovx control group. Furthermore, tibolone or EE decreased the mineralizing surface and bone formation rate as well as the osteoclast surface and osteoclast numbers. 1Alpha(OH)D3, however, did not affect these serum and urinary parameters. These data suggest that tibolone suppresses the accelerated bone turnover induced by a combination of ovariectomy and low dietary calcium, and indicate that tibolone may be a potentially useful drug for the treatment of postmenopausal osteoporosis.
Collapse
Affiliation(s)
- K Yoshitake
- Pharmacology Group, R&D Laboratories, Nippon Organon K.K., Osaka, Japan
| | | | | | | | | | | |
Collapse
|
39
|
Kagawa M, Murakoshi N, Nishikawa Y, Matsumoto G, Kurata Y, Mizobata T, Kawata Y, Nagai J. Purification and cloning of a thermostable manganese catalase from a thermophilic bacterium. Arch Biochem Biophys 1999; 362:346-55. [PMID: 9989945 DOI: 10.1006/abbi.1998.1041] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We have purified a heat-stable catalase from a thermophilic bacterium, Thermus species strain YS 8-13. The enzyme was purified 160-fold from crude cellular extracts and possessed a specific activity of 8000 units/mg at 65 degrees C. The purified enzyme displayed the highest activity at pH 7 to 10 and temperatures around 85 degrees C. The catalase was determined to be a manganese catalase, based on results from atomic absorption spectra and inhibition experiments using sodium azide. The enzyme was composed of six identical subunits of molecular weight 36,000. Amino acid sequences determined from the purified protein were used to design oligonucleotide primers, which were in turn used to clone the coding gene. The nucleotide sequence of a 1.4-kb fragment of Thermus sp. YS 8-13 genomic DNA containing a 909-bp open reading frame was determined. The gene encoded a 302-residue polypeptide of deduced molecular weight 33,303. The deduced amino acid sequence displayed a region-specific homology with the sequences of the manganese catalase from a mesophilic organism, Lactobacillus plantarum.
Collapse
Affiliation(s)
- M Kagawa
- Faculty of Engineering, Tottori University, Koyama-Minami, Tottori, 680-8552, Japan
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Takeshita M, Kagawa M, Izawa M, Takakura K. Current treatment strategies and factors influencing outcome in patients with bacterial brain abscess. Acta Neurochir (Wien) 1999; 140:1263-70. [PMID: 9932127 DOI: 10.1007/s007010050248] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
We clearly determined the key to managing patients with brain abscess by retrospectively evaluating the factors affecting poor outcome in these patients. This study included 113 patients with brain abscess diagnosed in the CT era. Basic characteristics and therapeutic parameters were estimated as independent predictors of poor outcome by using univariate and multivariate logistic regression analysis. Patients with poor outcomes more frequently had deeply-located abscesses (p < 0.02), IVROBA (intraventricular rupture of brain abscess (p < 0.001) and were in a severely deteriorated neurological state (p < 0.001) than those with good outcomes. Multiple logistic regression analysis predicted that IVROBA (ORs, 24.5; 95% CI, 3.04 to 197.9) and severely deteriorated cases (ORs, 13.7; 95% CI, 2.34 to 80.8) resulting from IVROBA increased the relative risk of poor outcome. Patients with IVROBA more frequently had also deeply-located abscesses (p < 0.005), positively immunocompromised states (p < 0.05) and were in a severely deteriorated condition (p < 0.003) than those without IVROBA. Patients with metastatic abscess had also IVROBA (p < 0.006). Multiple logistic regression analysis anticipated that deeply-located abscess (ORs, 3.90; 95% CI, 1.38 to 11.04), and metastatic abscess (ORs, 12.26; 95% CI, 1.35 to 111.2) increased the relative risk of IVROBA. Patients in an obtunded state and with marked neurological deficit had IVROBA more often than patients in an alert state and/or mild neurological deficit (ORs, 3.23; 95% CI, 1.17 to 8.86, p < 0.03) before treatment. Our findings suggest that IVROBA strongly influences poor outcome in patients with brain abscess. The key to decreasing poor outcomes may be the prevention and management of IVROBA, by evaluating intracranial pressure pathophysiology. IVROBA should be aggressively treated by aspiration methods for the abscess coupled with appropriate intravenous and intrathecial administration of antibiotics.
Collapse
Affiliation(s)
- M Takeshita
- Department of Neurosurgery, Tokyo Women's Medical University, Japan
| | | | | | | |
Collapse
|
41
|
Fukuyama Y, Minami H, Kagawa M, Kodama M, Kawazu K. Chemical conversion of vibsanin C to vibsanin E and structure of 3-hydroxyvibsanin E from viburnum awabuki. J Nat Prod 1999; 62:337-339. [PMID: 10075780 DOI: 10.1021/np980338v] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Vibsanin E (4), a tricyclic vibsane-type diterpene, has been prepared in 50% yield from vibsanin C (2), a seven-membered ring vibsane-type diterpene by reaction with BF3.OEt2 at -78 degrees C. This chemical correlation not only established structure, including absolute configurations, but also has demonstrated a possible biosynthetic route to 4 via 2 derived from vibsanin B (1). The structure of 3-hydroxyvibsanin E (5), another example of a tricyclic seven-membered ring vibsane, isolated from the leaves of Viburnumawabuki, has been established by extensive analyses of 2D NMR data and comparison of its spectral data with those of 4.
Collapse
Affiliation(s)
- Y Fukuyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan, and Department of Bioresources, Okayama University, Tsushima, Okayama, 700-8530, Japan
| | | | | | | | | |
Collapse
|
42
|
Sado Y, Kagawa M, Naito I, Ueki Y, Seki T, Momota R, Oohashi T, Ninomiya Y. Organization and expression of basement membrane collagen IV genes and their roles in human disorders. J Biochem 1998; 123:767-76. [PMID: 9562604 DOI: 10.1093/oxfordjournals.jbchem.a022003] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Six distinct genes have been identified as belonging to the type IV collagen gene family. They can be organized into three sets, i.e., COL4A1/COL4A2, COL4A3/COL4A4, and COL4A5/COL4A6, which are localized on three different chromosomes in humans, 13, 2, and X, respectively. Within each set the genes are aligned head-to-head and their expression is regulated by bidirectional promoters between the genes. Transcriptional regulation of the COL4A1/COL4A2 set has been well characterized. The transcription of COL4A6 seems to be controlled by two alternative promoters. While collagen IV molecules composed of alpha1 and alpha2 chains are broadly distributed, molecules comprising combinations of the other four chains, alpha3-alpha6, are important components of specialized basement membranes. The precise chain composition of triple-helical molecules assembled from the alpha3-alpha6 chains is not entirely clear, but it is hypothesized that alpha3-alpha5 chains and alpha5 and alpha6 chains form heterotrimeric molecules. Several pieces of evidence indicate that alpha3/alpha4/alpha5 molecules and alpha5/alpha6 molecules are components of the basement membrane network. This helps explain the observation that the kidney and skin basement membranes from patients with Alport syndrome caused by mutations in the alpha5 coding gene, COL4A5, are defective in the alpha3, alpha4, and alpha6 chains together with the alpha5 chain. Large deletions involving the COL4A5 and COL4A6 genes have been found in rare cases of diffuse leiomyomatosis associated with Alport syndrome.
Collapse
Affiliation(s)
- Y Sado
- Division of Immunology Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, USA
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Sado Y, Boutaud A, Kagawa M, Naito I, Ninomiya Y, Hudson BG. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen. Kidney Int 1998; 53:664-71. [PMID: 9507212 DOI: 10.1046/j.1523-1755.1998.00795.x] [Citation(s) in RCA: 81] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The capability of the noncollagenous (NC1) domains of the six alpha chains of human type IV collagen to induce anti-glomerular basement membrane (GBM) nephritis in WKY rats was determined. This was accomplished by using recombinant technology to express the six NC1 domains in mammalian 293 cells and to purify the proteins using an anti-Flag affinity column. All rats injected with alpha 3(IV)NC1 and alpha 4(IV)NC1 developed proteinuria and hematuria. Rats injected with alpha 5(IV)NC1 developed mild hematuria, whereas rats injected with the alpha 1(IV)NC1, alpha 2(IV)NC1 and alpha 6(IV)NC1 domains developed neither proteinuria nor hematuria. The renal lesions induced by alpha 3(IV)NC1 and alpha 4(IV)NC1 domains were characteristic of those in patients with anti-GBM nephritis and Goodpasture syndrome. The experimental nephritis is mediated by anti-basement membrane antibodies that are targeted to alpha 3(IV)NC1 and alpha 4(IV)NC1 domains and which bind to the glomerular basement membrane. The uniqueness of the alpha 3(IV)NC1 and alpha 4(IV)NC1 domains, among the six NC1 domains, to induce severe anti-GBM disease may relate to the accessibility of epitopes in the GBM for binding of antibody. The pathogenicity of the alpha 4(IV)NC1 antibodies establishes a conundrum because the pathogenic antibodies in patients are not targeted to the alpha 4(IV)NC1, but are targeted to the alpha 3(IV)NC1 domain in anti-GBM nephritis and to the alpha 3(IV)NC1 and alpha 5(IV)NC1 domains in Alport post-transplant anti-GBM nephritis.
Collapse
Affiliation(s)
- Y Sado
- Division of Immunology, Shigei Medical Research Institute, Okayama, Japan
| | | | | | | | | | | |
Collapse
|
44
|
Naito I, Nomura S, Inoue S, Kagawa M, Matsubara T, Araki T, Taki M, Ohmori H, Manabe K, Kawai S, Osawa G, Sado Y. X-linked Alport syndrome with normal distribution of collagen IV alpha chains in epidermal basement membrane. Contrib Nephrol 1997; 122:134-9. [PMID: 9399056 DOI: 10.1159/000059891] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- I Naito
- Division of Ultrastructural Biology, Shigei Medical Research Institute, Okayama, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Takeshita M, Kagawa M, Yato S, Izawa M, Onda H, Takakura K, Momma K. Current treatment of brain abscess in patients with congenital cyanotic heart disease. Neurosurgery 1997; 41:1270-8; discussion 1278-9. [PMID: 9402578 DOI: 10.1097/00006123-199712000-00006] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVE The goal of this study was to define clearly the role of management in patients with cyanotic heart disease and brain abscesses by evaluating retrospectively the factors influencing poor outcome in these patients. METHODS This study included 62 patients with cyanotic heart disease and brain abscesses diagnosed in the computed tomography era. Basic characteristic parameters (number, size, location, computed tomographic classification and organism type of abscess, convulsion, type of cyanotic heart disease, age distribution, immunocompromised status, pretreatment neurological state, and intraventricular rupture of brain abscess [IVROBA]) and therapeutic parameters (type of antibiotics and duration of administration, steroid medication and therapeutic modalities, aspiration with or without cerebrospinal fluid drainage, total extirpation after aspiration, or primary extirpation and medical treatment) were evaluated as independent predictors of poor outcome (totally disabled state or death) by using univariate and multivariate logistic regression analysis. We also statistically estimated the possible causes of IVROBA and the multiplicity of brain abscess. RESULTS Although there were no statistically significant correlations between patients with good and poor outcomes in regard to other basic characteristic and therapeutic parameters, patients with poor outcomes were older (P < 0.02), more frequently had IVROBA (P < 0.005), and had a higher frequency of neurological deterioration (P < 0.01) than those with good outcomes. Multiple logistic regression analysis predicted that poor outcome increased the relative risk of IVROBA by a factor of 18.9 (odds rate, 18.9; 95% confidence interval, 1.7-211.6; P < 0.02). More patients with multiple abscesses had positive immunocompromised states than those with single abscesses (P < 0.01). Deep-located abscesses also more frequently had IVROBA (P < 0.005) and abscesses located in the parieto-occipital region ruptured into the occipital horn of the lateral ventricle in a short period (P < 0.02). CONCLUSIONS Our findings suggest that IVROBA strongly influences poor outcome in patients with cyanotic heart disease. The key to decreasing poor outcomes may be the prevention and management of IVROBA. To reduce operative and anesthetic risk in these patients, abscesses should be managed by less invasive aspiration methods guided by computed tomography. Abscesses larger than 2 cm in diameter, in deep-located or parieto-occipital regions, should be aspirated immediately and repeatedly, mainly using computed tomography-guided methods to decrease intracranial pressure and avoid IVROBA. IVROBA should be aggressively treated by aspiration methods for the abscess coupled with the appropriate intravenous and intrathecal administration of antibiotics while evaluating intracranial pressure pathophysiology.
Collapse
Affiliation(s)
- M Takeshita
- Department of Neurosurgery, Heart Institute of Japan, Tokyo Women's Medical College, Japan
| | | | | | | | | | | | | |
Collapse
|
46
|
Naito I, Nomura S, Inoue S, Kagawa M, Kawai S, Gunshin Y, Joh K, Tsukidate C, Sado Y, Osawa G. Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. J Clin Pathol 1997; 50:919-22. [PMID: 9462240 PMCID: PMC500315 DOI: 10.1136/jcp.50.11.919] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Epstein's syndrome is defined as a subtype of Alport's syndrome, and is distinguished from the other subtypes by accompanying macrothrombocytopenia. Mutations in collagen IV genes are known to be involved in the pathogenesis of typical Alport's syndrome. However, the presence of an underlying genetic defect has not been demonstrated in Epstein's syndrome. AIM To clarify the involvement of collagen IV in Epstein's syndrome. METHODS The distribution of the alpha(IV) chain was studied in renal specimens obtained from three patients with Epstein's syndrome using chain specific monoclonal antibodies and an antigen retrieval procedure. RESULTS The patients showed a normal distribution of alpha(IV) chains: alpha 1(IV) and alpha 2(IV) were expressed ubiquitously, whereas expression of alpha 3(IV) through to alpha 6(IV) chains was limited to the glomerular basement membrane, Bowman's capsular basement membrane, and/or a portion of the tubular basement membrane. CONCLUSIONS These results suggest that genes other than those encoding alpha(IV) chains are responsible for the pathogenesis of Epstein's syndrome.
Collapse
Affiliation(s)
- I Naito
- Division of Ultrastructural Biology, Shigei Medical Research Institute, Okayama, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Takeshita M, Kagawa M, Yato S, Izawa M, Onda H, Takakura K. Management of brain abscess in patients with congenital cyanotic heart disease. Clin Neurol Neurosurg 1997. [DOI: 10.1016/s0303-8467(97)81358-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
48
|
Abstract
Human nephritogenic antigen induces anti-glomerular basement membrane antibody glomerulonephritis in rats. This antigen was purified from collagenase-solubilized renal basement membrane by means of gel filtration and affinity chromatography using a rabbit antibody. Western blots of the purified nephritogenic antigen using epitope-defined monoclonal antibodies showed that it contains the NC1 domains of the a1 to a6 chains of type IV collagen. Nephritogenicity was thought to be a feature of the NC1 domains of the a3 to a5 chains, because the a6 chain is not located in the glomerular basement membrane, and because an NC1 fraction consisting of the NC1 domains of the a1 and a2 chains was poorly nephritogenic. Autoantibodies in the sera of patients with Goodpasture's syndrome were detected by ELISA using the purified nephritogenic antigen. These results indicate that the nephritogenic antigen contains the Goodpasture antigen, defined as the antigen reactive with sera from patients with Goodpasture's syndrome.
Collapse
Affiliation(s)
- Y Sado
- Division of Immunology, Shigei Medical Research Institute, Okayama, Japan
| | | | | | | | | | | |
Collapse
|
49
|
Kagawa M, Kishiro Y, Naito I, Nemoto T, Nakanishi H, Ninomiya Y, Sado Y. Epitope-defined monoclonal antibodies against type-IV collagen for diagnosis of Alport's syndrome. Nephrol Dial Transplant 1997; 12:1238-41. [PMID: 9198058 DOI: 10.1093/ndt/12.6.1238] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND Alport's syndrome can be diagnosed by staining the alpha 5 chain of type IV collagen in kidney biopsy specimens with a monoclonal antibody. Because antibodies already established against the alpha 5 chain require denaturation treatment of cryostat sections to expose their epitopes. To save time and effort for staining, a new epitope-defined monoclonal antibody whose epitope is initially exposed on the surface of the molecule was established. METHODS Two monoclonal antibodies against the triple-helical domains of the type IV collagen alpha 2 and alpha 5 chains were established with synthetic peptides as immunogens by the rat lymph node method. Their epitope were EAIQP at the positions of 675-679 of the alpha 2 chain, and IDVEF at the positions of 251-255 of the alpha 5 chain, respectively. They were purified with synthetic peptide-coupled affinity columns, and then conjugated with Texas red and FITC, respectively. RESULTS The mixture of fluorochrome-conjugated antibodies was able to detect the distribution of the alpha 2 and alpha 5 chains in the normal and Alport kidney and skin by direct immunofluorescence staining with and without denaturation treatment of the sections. CONCLUSIONS The direct double immunofluorescence staining of kidney and skin cryostat sections with the fluorochrome-conjugated antibodies is useful, reliable, and convenient for diagnosis of Alport's syndrome.
Collapse
Affiliation(s)
- M Kagawa
- Division of Immunology, Shigei Medical Research Institute, Okayama, Japan
| | | | | | | | | | | | | |
Collapse
|
50
|
Sado Y, Kagawa M. [An efficient, antigen-saving, labor-saving, and time-saving technique for making monoclonal antibodies with enlarged rat lymph nodes]. Seikagaku 1997; 69:128-131. [PMID: 9086844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- Y Sado
- Division of Immunology, Shigei Medical Research Institute, Okayama
| | | |
Collapse
|